Incretin hormones as a target for therapy

Jens Juul Holst

doi:10.1007/978-3-319-08982-9_2

Incretin hormones as a target for therapy

Abstract

Incretin hormones are responsible for the incretin effect, which is the amplification of insulin secretion when nutrients are taken in orally, as opposed to intravenously.

Originalsprog	Engelsk
Titel	Handbook of Incretin-based Therapies in Type 2 Diabetes
Redaktører	Stephen Gough
Forlag	Springer
Publikationsdato	7 jun. 2016
Sider	11-30
Kapitel	20
ISBN (Trykt)	978-3-319-08981-2
ISBN (Elektronisk)	978-3-319-08982-9
DOI	https://doi.org/10.1007/978-3-319-08982-9_2
Status	Udgivet - 7 jun. 2016

Adgang til dokumentet

10.1007/978-3-319-08982-9_2

Citationsformater

@inbook{d13ec0d27e414213a8599da47e5473cf,

title = "Incretin hormones as a target for therapy",

abstract = "Incretin hormones are responsible for the incretin effect, which is the amplification of insulin secretion when nutrients are taken in orally, as opposed to intravenously.",

author = "Holst, {Jens Juul}",

year = "2016",

month = jun,

day = "7",

doi = "10.1007/978-3-319-08982-9_2",

language = "English",

isbn = "978-3-319-08981-2",

pages = "11--30",

editor = "Stephen Gough",

booktitle = "Handbook of Incretin-based Therapies in Type 2 Diabetes",

publisher = "Springer",

}

TY - CHAP

T1 - Incretin hormones as a target for therapy

AU - Holst, Jens Juul

PY - 2016/6/7

Y1 - 2016/6/7

N2 - Incretin hormones are responsible for the incretin effect, which is the amplification of insulin secretion when nutrients are taken in orally, as opposed to intravenously.

AB - Incretin hormones are responsible for the incretin effect, which is the amplification of insulin secretion when nutrients are taken in orally, as opposed to intravenously.

U2 - 10.1007/978-3-319-08982-9_2

DO - 10.1007/978-3-319-08982-9_2

M3 - Book chapter

SN - 978-3-319-08981-2

SP - 11

EP - 30

BT - Handbook of Incretin-based Therapies in Type 2 Diabetes

A2 - Gough, Stephen

PB - Springer

ER -